HCA Healthcare (NYSE:HCA) versus Precipio (NASDAQ:PRPO) Head to Head Review

Precipio (NASDAQ:PRPO – Get Free Report) and HCA Healthcare (NYSE:HCA – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Profitability

This table compares Precipio and HCA Healthcare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Precipio -4.12% -7.84% -5.37%
HCA Healthcare 8.61% -198.52% 10.81%

Institutional and Insider Ownership

10.4% of Precipio shares are held by institutional investors. Comparatively, 62.7% of HCA Healthcare shares are held by institutional investors. 16.6% of Precipio shares are held by company insiders. Comparatively, 1.5% of HCA Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Precipio and HCA Healthcare”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Precipio $27.76 million 1.29 -$360,000.00 ($0.59) -33.83
HCA Healthcare $78.70 billion 1.36 $6.78 billion $30.18 16.95

HCA Healthcare has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for Precipio and HCA Healthcare, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precipio 1 0 0 0 1.00
HCA Healthcare 1 7 16 0 2.62

HCA Healthcare has a consensus target price of $480.13, suggesting a potential downside of 6.13%. Given HCA Healthcare’s stronger consensus rating and higher possible upside, analysts clearly believe HCA Healthcare is more favorable than Precipio.

Volatility & Risk

Precipio has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, HCA Healthcare has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.

Summary

HCA Healthcare beats Precipio on 11 of the 14 factors compared between the two stocks.

About Precipio

(Get Free Report)

Precipio is a diagnostics company focused on hematologic cancers and other complex diseases. It provides specialized pathology and laboratory testing services to help physicians identify and characterize blood disorders and malignancies. The company also develops and sells diagnostic products for use by clinical laboratories. Its HemeScreen platform offers molecular testing for genetic mutations associated with blood cancers, while its broader product offerings support laboratories seeking to perform specialized diagnostic tests.

About HCA Healthcare

(Get Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.